Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine.

Green, J A; Slater, A J; Campbell, I R; Kelly, V

Green, J A; Slater, A J; Campbell, I R; Kelly, V.

Affiliation

Green JA; Clatterbridge Centre for Oncology, Bebington, Wirral, England.

Breast Cancer Res Treat ; 39(2): 155-63, 1996.

Article in En | MEDLINE | ID: mdl-8872324

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/mortality; Breast Neoplasms/pathology; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Female; Hematopoiesis/drug effects; Humans; Middle Aged; Mitoxantrone/administration & dosage; Survival Rate; Treatment Outcome; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 1996 Document type: Article Affiliation country: United kingdom Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links